For research use only
| Cat No. | ABC-SC0022T |
| Product Type | Human iPSCs |
| Cell Type | Induced Pluripotent Stem Cell |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Fibroblast |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Human iPS (induced pluripotent stem) cell line was derived from human foreskin fibroblasts (HFFs)
HighQC™ Human iPSC (From Fibroblast/ Male/ Retrovirus) is an induced pluripotent stem cell line derived from dermal fibroblasts of a healthy male donor, using morphological selection criteria without the use of fluorescent markers or drug selection. These cells are generated by transducing four transcription factors, Oct3/4, Sox2, Klf4, and c-Myc, into human fibroblasts using retroviral vectors. They exhibit expression of the pluripotency markers SSEA-3 and Nanog. Additionally, the cell line demonstrates strong endogenous alkaline phosphatase activity. While it retains the potential to differentiate into lineages of all three germ layers, the cell line remains a valuable resource for investigating cellular reprogramming and early lineage commitment. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, syphilis, mycoplasma, fungi, yeast, and bacteria.
| Product Code | HighQC™ Human IPSC From Foreskin Fibroblasts/ Male/ Retrovirus, Human iPSC-Fib-Male-RV, hIPSC-Fib-Male-RV, Human Retrovirus Transduced Foreskin iPSC |
| Species | Human |
| Cat.No | ABC-SC0022T |
| Product Category | Stem Cells |
| Size/Quantity | 1 vial |
| Cell Type | Induced Pluripotent Stem Cell |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Fibroblast |
| Disease | Normal |
| Storage | Liquid Nitrogen |
| Product Type | Human iPSCs |
HighQC™ Human iPSC (From Fibroblast/ Male/ Retrovirus) serves as a robust in vitro model for studying genetic disorders, developmental mechanisms, and early reprogramming dynamics. Their application includes functional genomics to dissect molecular pathways underlying neurodevelopmental and cardiovascular phenotypes, facilitating drug screening and target validation for candidate compounds, providing a platform to investigate gene dosage effects and evaluate potential corrective strategies.
When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).